San Antonio, TX—Triple-negative breast cancer is a biologically heterogeneous disease, one for which chemotherapy remains the mainstay, at least for the moment, said Lisa A. Carey, MD, Medical Director, University of North Caroline Breast Center, Lineberger Comprehensive Cancer Center, Chapel Hill, at the 2013 San Antonio Breast Cancer Symposium.
San Antonio, TX—Effective symptom management and preservation of quality of life are the most important goals in caring for patients with metastatic breast cancer, said Polly Nirvath, MD, Associate Professor, Smith Breast Center, Baylor College of Medicine, Houston, TX, at the 2013 San Antonio Breast Cancer Symposium.
Of patients with metastatic breast cancer, 10% to 15% have known brain metastases, but with median survival after brain metastases now reaching almost 2 years, quality of life is paramount, said Dr Nirvath.
San Antonio, TX—The controversy over the value of breast cancer screening in reducing breast cancer mortality is largely an artificial one that dissipates once methods that take into account lead time and underlying incidence trends are applied to data sets, said Robert Smith, PhD, Senior Director of Cancer Screening at the American Cancer Society, Atlanta, GA, at the 2013 San Antonio Breast Cancer Symposium.
Results 1 - 4 of 4